HomeExpertisePostersACoP 2026, Oxon Hill, MD, USQSP Model of PSMAxCD3 T-cell Engagers Generates Cytokine-based CRS Risk and Efficacy-related Biomarker Predictions to Optimize Clinical Dosing Strategies
We use cookies (and other similar technologies) to collect data to improve your experience on our site.
By using our website, you agree to data collection as described in our website’s data collection policy.